Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.93 USD | -5.64% | -4.56% | -49.48% |
Financials (USD)
Sales 2024 * | 65.3M | Sales 2025 * | 6.25M | Capitalization | 19.52M |
---|---|---|---|---|---|
Net income 2024 * | 26M | Net income 2025 * | -40M | EV / Sales 2024 * | 0.3 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.12 x |
P/E ratio 2024 * |
0.81
x | P/E ratio 2025 * |
-0.51
x | Employees | 46 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.46% |
Latest transcript on MEI Pharma, Inc.
1 day | -5.64% | ||
1 week | -4.56% | ||
Current month | -3.93% | ||
1 month | -8.44% | ||
3 months | -33.26% | ||
6 months | -52.28% | ||
Current year | -49.48% |
Managers | Title | Age | Since |
---|---|---|---|
David Urso
CEO | Chief Executive Officer | 60 | 14-03-06 |
Justin File
DFI | Director of Finance/CFO | 53 | 23-06-11 |
Caroline Ruiz
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 74 | 18-02-25 |
Thomas Reynolds
BRD | Director/Board Member | 65 | 13-02-10 |
Charles Baltic
CHM | Chairman | 63 | 11-10-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 2.93 | -5.64% | 61,822 |
24-05-15 | 3.105 | -1.74% | 29,032 |
24-05-14 | 3.16 | +1.28% | 14,847 |
24-05-13 | 3.12 | +3.31% | 9,987 |
24-05-10 | 3.02 | -1.63% | 8,473 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.48% | 20.69M | |
+33.37% | 49.46B | |
+1.55% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
-21.00% | 18.64B | |
+7.36% | 13.16B | |
+28.30% | 12.55B | |
+23.80% | 12.1B |
- Stock Market
- Equities
- MEIP Stock